Moistu-eyes
NDC Package 72362-101-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Moistu-eyes is pull lower lid down to form a pouch and apply a small strip of ointment to it.Repeat this treatment as often as needed or as directed by your doctor. Marketed by Brassica Pharma Private Limited, this product is identified by NDC 72362-101 and is authorized under FDA application part349.

Identification & Billing

NDC Package Code
72362-101-01
Package Description
1 TUBE in 1 CARTON / 3.5 g in 1 TUBE
Product Code
72362-101
11-Digit Billing Format
72362010101
RxNorm Crosswalk
  • RxCUI: 702008 - mineral oil 42.5 % / petrolatum 57.3 % Ophthalmic Ointment
  • RxCUI: 702008 - mineral oil 0.425 MG/MG / petrolatum 0.573 MG/MG Ophthalmic Ointment
  • RxCUI: 702008 - mineral oil 42.5 % / petrolatum, white 57.3 % Ophthalmic Ointment

Clinical Specifications

Proprietary Name
Moistu-eyes
Dosage Form
-
Usage Information
Pull lower lid down to form a pouch and apply a small strip of ointment to it.Repeat this treatment as often as needed or as directed by your doctor. If you get any side effects, talk to your doctor, pharmacist or nurse.

Regulatory & Marketing

Labeler Name
Brassica Pharma Private Limited
FDA Application #
part349
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
06-11-2018
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (72362-101). Click a package code to view its specific billing and regulatory data.

72362-101-02
1 TUBE in 1 CARTON / 5 g in 1 TUBE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72362-101-01 identifies a specific commercial package of 1 tube in 1 carton / 3.5 g in 1 tube of Moistu-eyes, labeled by Brassica Pharma Private Limited. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Brassica Pharma Private Limited on June 11, 2018. The current certification is valid through December 31, 2021.

How is this Brassica Pharma Private Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72362010101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72362-101-01
11-Digit CMS (5-4-2)
72362-0101-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.